Credit Suisse’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $123K | Buy |
|
|||||
|
2022
Q4 | $395K | Buy |
|
|||||
|
2022
Q3 | $553K | Sell |
|
|||||
|
2022
Q2 | $674K | Sell |
|
|||||
|
2022
Q1 | $1.11M | Buy |
|
|||||
|
2021
Q4 | $2.18M | Sell |
|
|||||
|
2021
Q3 | $3.35M | Buy |
|
|||||
|
2021
Q2 | $2.98M | Sell |
|
|||||
|
2021
Q1 | $4.2M | Sell |
|
|||||
|
2020
Q4 | $4.1M | Sell |
|
|||||
|
2020
Q3 | $13.6M | Sell |
|
|||||
|
2020
Q2 | $22.6M | Sell |
|
|||||
|
2020
Q1 | $21.5M | Buy |
|
|||||
|
2019
Q4 | $14.5M | Sell |
|
|||||
|
2019
Q3 | $14.5M | Buy |
|
|||||
|
2019
Q2 | $20.3M | Buy |
|
|||||
|
2019
Q1 | $15.9M | Sell |
|
|||||
|
2018
Q4 | $15.6M | Sell |
|
|||||
|
2018
Q3 | $30M | Buy |
|
|||||
|
2018
Q2 | $22.4M | Buy |
|
|||||
|
2018
Q1 | $41.7M | Buy |
|
|||||
|
2017
Q4 | $20.2M | Sell |
|
|||||
|
2017
Q3 | $8.8M | Buy |
|
|||||
|
2017
Q2 | $5.75M | Sell |
|
|||||
|
2017
Q1 | $8.12M | Sell |
|
|||||
|
2016
Q4 | $6.51M | Buy |
|
|||||
|
2016
Q3 | $8.59M | Buy |
|
|||||
|
2016
Q2 | $6.9M | Buy |
|
|||||
|
2016
Q1 | $5.39M | Sell |
|
|||||
|
2015
Q4 | $6.88M | Sell |
|
|||||
|
2015
Q3 | $4.56M | Sell |
|
|||||
|
2015
Q2 | $8.28M | Buy |
|
|||||
|
2015
Q1 | $5.02M | Sell |
|
|||||
|
2014
Q4 | $7.93M | Buy |
|
|||||
|
2014
Q3 | $4.62M | Buy |
|
|||||
|
2014
Q2 | $3.79M | Buy |
|
|||||
|
2014
Q1 | $3.23M | Sell |
|
|||||
|
2013
Q4 | $3.1M | Buy |
|
|||||
|
2013
Q3 | $2.01M | Sell |
|
|||||
|
2013
Q2 | $5.07M | Buy |
|